Operating, investing and financing flows differ from the reported change in cash by 2500000, beyond tolerance 2215000.00.
Cushman & Wakefield Ltd. (CWK) reported revenue of $2.76B and net income of $52.70M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Cushman & Wakefield Ltd.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Real Estate.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $2.54B | $2.91B | $2.61B | $2.48B | $2.28B | $2.63B | $2.34B | $2.29B | $2.18B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $134.20M | $58.70M | $176.90M | $107.50M | $122.80M | $45.30M | $174.50M | $75.20M | $70.40M | $18.80M |
| Net income | $52.70M | -$12.60M | -$22.40M | $51.40M | $57.30M | $1.90M | $112.90M | $33.70M | $13.50M | -$28.80M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 236.30M | shares 232.80M | Unavailable | shares 235.90M | shares 232.40M | shares 232.30M | Unavailable | shares 233.40M | shares 231.50M | shares 227.90M |
| Pretax income | Unavailable | Unavailable | -$12.10M | $45.10M | $76.20M | $5.00M | $132.10M | $53.00M | $17.20M | -$26.50M |
| Income tax expense | $24.60M | $3.00M | $10.30M | -$6.30M | $18.90M | $3.10M | $19.20M | $19.30M | $3.70M | $2.30M |
| Diluted EPS | $0.22 | $-0.05 | Unavailable | $0.22 | $0.25 | $0.01 | Unavailable | $0.14 | $0.06 | $-0.13 |
| Selling, general & administrative | $349.30M | $336.70M | $372.50M | $320.60M | $318.30M | $305.80M | $319.70M | $314.20M | $294.20M | $296.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $500.50M | $600.60M | $784.20M | $634.40M | $618.20M | $623.20M | $793.30M | $775.40M | $567.30M | $553.50M |
| Total assets | $7.55B | $7.65B | $7.68B | $7.69B | $7.56B | $7.41B | $7.55B | $7.53B | $7.34B | $7.49B |
| Current assets | $2.63B | $2.75B | $2.84B | $2.67B | $2.64B | $2.60B | $2.69B | $2.65B | $2.59B | $2.46B |
| Total liabilities | $5.53B | $5.70B | $5.72B | $5.73B | $5.65B | $5.63B | $5.79B | $5.83B | $5.70B | $5.87B |
| Current liabilities | $2.44B | $2.43B | $2.59B | $2.51B | $2.33B | $2.20B | $2.33B | $2.24B | $2.14B | $2.18B |
| Total equity incl. NCI | $2.02B | $1.95B | $1.96B | $1.96B | $1.90B | $1.78B | $1.76B | $1.70B | $1.64B | $1.63B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $2.06B | $2.06B | $2.06B | $2.06B | $2.06B | $2.02B | $2.00B | $2.05B | $2.02B | $2.06B |
| Long-term debt | $2.41B | $2.62B | $2.62B | $2.72B | $2.82B | $2.91B | $2.94B | $3.00B | $3.00B | $3.07B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $54.00M | -$243.50M | $257.30M | $235.50M | $9.60M | -$162.00M | $115.20M | $196.10M | $21.80M | -$125.10M |
| Capital expenditures | $8.50M | $12.20M | $23.00M | $10.50M | $9.30M | $4.60M | $9.30M | $9.40M | $11.80M | $10.50M |
| Investing cash flow | -$35.90M | $94.10M | $7.90M | -$60.10M | $10.50M | $20.60M | -$33.10M | $57.40M | $67.70M | -$10.80M |
| Financing cash flow | -$116.10M | -$28.10M | -$117.40M | -$155.50M | -$36.30M | -$41.30M | -$55.90M | -$57.00M | -$67.60M | -$72.90M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $12.70M | $16.30M | $14.10M | $14.00M | $14.10M | $16.00M | $13.30M | $10.40M | $5.50M | $6.40M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $28.50M | $25.30M | $25.50M | $25.80M | $26.20M | $26.70M | $29.60M | $28.90M | $31.20M | $32.50M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $45.50M | -$255.70M | $234.30M | $225.00M | $300.00K | -$166.60M | $105.90M | $186.70M | $10.00M | -$135.60M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 4.9% | 2.3% | 6.1% | 4.1% | 4.9% | 2.0% | 6.6% | 3.2% | 3.1% | 0.9% |
| FCF margin | 1.6% | -10.1% | 8.0% | 8.6% | 0.0% | -7.3% | 4.0% | 8.0% | 0.4% | -6.2% |
| SBC / revenue | 0.5% | 0.6% | 0.5% | 0.5% | 0.6% | 0.7% | 0.5% | 0.4% | 0.2% | 0.3% |
| Current ratio | 1.08x | 1.13x | 1.10x | 1.07x | 1.13x | 1.18x | 1.15x | 1.18x | 1.21x | 1.13x |
| Revenue YoY growth | 11.2% | 11.0% | 10.8% | 11.2% | 8.6% | 4.6% | 3.0% | 2.5% | -4.9% | -2.9% |
| Net margin | 1.9% | -0.5% | -0.8% | 2.0% | 2.3% | 0.1% | 4.3% | 1.4% | 0.6% | -1.3% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.3% | 0.5% | 0.8% | 0.4% | 0.4% | 0.2% | 0.4% | 0.4% | 0.5% | 0.5% |
| Long-term debt / equity | 1.19x | Unavailable | 1.34x | 1.39x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | -14.0% | Unavailable | Unavailable | 14.5% | 36.4% | 21.5% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CWK in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Operating, investing and financing flows differ from the reported change in cash by 16800000, beyond tolerance 2437000.00.